CHI’s successful Alliance Management Congress is growing! Our growth mirrors recent survey results collected from eighty-nine thought leaders in alliance management, diagnostics, medical devices, and licensing. In light of the economy and state of industry, 88% deem alliances as critical and essential to their organization’s alliance activity. During the next 9-12 months, 84% will grow their alliances with new partners including those from academic institutions, diagnostics, medical devices, and international markets.

The Collaborations, Deals, and Alliances Congress will house the 7th Annual Alliance Management Congress, the inaugural conference on Collaboration and Deal Making Strategies to Commercialize Molecular Diagnostics, and the 2nd Annual Combination Drug Therapies: Overcoming Challenges in the Development of Fixed Dose and Co-Packaged Combinations.

The Collaborations, Deals, and Alliances Congress is for Vice Presidents, Department Heads, Directors, and Managers of Alliance Management, Business Development, Licensing, R&D, Project Management, Clinical Development, and Drug Regulatory Affairs from pharmaceutical, biotech, diagnostics, and medical devices companies.

The Collaborations, Deals, and Alliances Congress offers novel case studies, strategies, and techniques from thought leaders who have real-world perspectives to share. There will be case studies of best practice examples, keynotes, industry trends and updates, interactive discussion groups, and panel discussions. The Collaborations, Deals, and Alliances Congress offers multiple conference tracks that provide education for an individual’s area of interest. The Collaborations, Deals, and Alliances Congress also offers joint sessions between the tracks and networking opportunities to provide cross-disciplinary learning.